Condition
Hematopoietic Cell Transplantation clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Hematopoietic Cell Transplantation clinical trials that are recruiting, at sites in 2 countries (most in United States (3), Hong Kong (1)). By phase: Phase 1 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 2Countries
Newest Hematopoietic Cell Transplantation clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| CD62L-depleted versus CD45RA-depleted donor lymphocyte infusions after haploidentical HSCT in children | Phase 2 | Hong Kong | Recruiting | Oct 9, 2026 |
| CD19‑CAR T‑cell consolidation after TCRαβ/CD19‑depleted haploidentical family donor transplant for relapsed/refractory CD19+ B‑cell leukemia and lymphoma | Phase 1 | Memphis, Tennessee | Recruiting | Dec 2, 2025 |
| Using parametric response mapping to detect lung injury in transplant patients | — | Stanford, California and 5 other locations | Recruiting | May 19, 2023 |
| Registry of Pediatric Patients Undergoing Hematopoietic Cell Transplantation | — | Rochester, Minnesota and 2 other locations | Recruiting | Oct 22, 2021 |
All recruiting trials (4)
-
CD62L-depleted versus CD45RA-depleted donor lymphocyte infusions after haploidentical HSCT in children
This trial tests whether using CD62L-depleted donor lymphocytes after a haploidentical HSCT works better or worse than CD45RA-depleted lymphocytes in children.
-
CD19‑CAR T‑cell consolidation after TCRαβ/CD19‑depleted haploidentical family donor transplant for relapsed/refractory CD19+ B‑cell leukemia and lymphoma
This will try giving CD19‑targeted CAR T cells shortly after a partially matched family‑donor transplant to children and young adults (≤21) with relapsed or refractory CD19+ B‑cell leukemia or lymphoma to see if the approach is safe and feasible.
-
Using parametric response mapping to detect lung injury in transplant patients
This study is testing if a new imaging method can help predict lung problems in transplant patients who have chronic graft versus host disease or chronic lung disease.
-
Registry of Pediatric Patients Undergoing Hematopoietic Cell Transplantation
This study is trying to see how common certain health problems are in kids and teens after they have a stem cell transplant and how these issues relate to their recovery and survival.
Related topics
Quick answers
How many Hematopoietic Cell Transplantation clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (3 trials), Hong Kong (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.